| 000 | 01581 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518042731.0 | ||
| 264 | 0 | _c20200616 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1664-3224 | ||
| 024 | 7 |
_a10.3389/fimmu.2019.01023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Aguiar, Rodrigo Barbosa | |
| 245 | 0 | 0 |
_aExploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors. _h[electronic resource] |
| 260 |
_bFrontiers in immunology _c2019 |
||
| 300 |
_a1023 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aDisease Susceptibility _ximmunology |
| 650 | 0 | 4 |
_aEpitopes _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xpharmacology |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunomodulation _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xetiology |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factors _xantagonists & inhibitors |
| 700 | 1 | _ade Moraes, Jane Zveiter | |
| 773 | 0 |
_tFrontiers in immunology _gvol. 10 _gp. 1023 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2019.01023 _zAvailable from publisher's website |
| 999 |
_c29756843 _d29756843 |
||